Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	SGX301	118
Overall Study	STARTED	Placebo	51
Overall Study	Randomized, Not Treated	SGX301	2
Overall Study	Randomized, Not Treated	Placebo	1
Overall Study	Cycle 1	SGX301	116
Overall Study	Cycle 1	Placebo	50
Overall Study	Cycle 2	SGX301	110
Overall Study	Cycle 2	Placebo	45
Overall Study	Cycle 3	SGX301	78
Overall Study	Cycle 3	Placebo	32
Overall Study	Follow-up Period	SGX301	98
Overall Study	Follow-up Period	Placebo	39
Overall Study	COMPLETED	SGX301	83
Overall Study	COMPLETED	Placebo	32
Overall Study	NOT COMPLETED	SGX301	35
Overall Study	NOT COMPLETED	Placebo	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02448381/flow